Tris(dichloromethylsilylethyl)borane is a compound containing a B–C bond and Cl and H elements. Herein, we propose a novel method to synthesize polyborosilazanes using tris(dichloromethylsilylethyl)borane and boron trichlorosilane as boron sources and hexamethyldisilazane as a nitrogen source. The microstructure and chemical composition of the as-synthesized polyborosilazanes and as-annealed SiBCN ceramics were investigated using Fourier transform infrared spectroscopy , nuclear magnetic resonance spectroscopy , Raman spectroscopy , scanning electron microscope, and transmission electron microscope methods. The organic precursors were converted entirely into inorganic ceramics at 800 °C, and the ceramic yield of the polyborosilazanes was 88% at 1000 °C. SiBCN ceramics with irregular shapes contained chemical bonds of B–N, Si–N, and Si–C at 1500 °C and retained an amorphous structure below 1600 °C. After the first cycle, the fabricated SiBCN ceramic anodes exhibited a reversible capacity of 261.3 mA h/g, which was 2.6 times that reported in the literature (101 mA h/g). The discharge capacity decreased to 157.6 mA h/g after 30 cycles. The satisfactory electrochemical performance of the resulting SiBCN ceramic anodes can be attributed to the formation of conductive carbon species favoring the transport properties of lithium ion .
Background Septic heart failure has been recognized as a puzzle since antiquity and poses a major challenge to modern medicine. Our previous work has demonstrated the potential effects of lycorine (LYC) on sepsis and septic myocardial injury. Nonetheless, further exploration is needed to elucidate the underlying cellular and molecular mechanisms. Methods In this study, we conducted transcriptome analysis and weighted gene co-expression network analysis (WGCNA) to identify the key genes and reveal the mechanism of LYC against septic heart failure. Purpose This study aims to apply bioinformatic analysis and experimental validations to explore the protective effects and underlying mechanism of LYC on the cecal ligation and puncture (CLP)-induced sepsis model mice. Results Transcriptome analysis revealed the differentially expressed genes (DEGs) following LYC treatment. WGCNA analysis identified gene modules associated with LYC-mediated protection, with BCL3 emerging as a core gene within these modules. Notably, BCL3 was an overlapping gene of DEGs and WGCNA core genes induced by LYC treatment, and is highly negatively correlated with cardiac function indicator. In vivo and in vitro study further prove that LYC exerted a protective effect against septic myocardial injury through inhibiting BCL3. BCL3 siRNA ameliorated LPS-induced cardiac injury and inflammation, while BCL3 overexpression reversed the protective effect of LYC against LPS injury. Conclusion In summary, our findings demonstrate the significant attenuation of septic myocardial disorder by LYC, with the identification of BCL3 as a pivotal target gene. This study is the first to report the role of BCL3 in sepsis and septic myocardial injury. Furthermore, the strategy for hub genes screening used in our study facilitates a comprehensive exploration of septic targets and reveals the potential targets for LYC effect. These findings may offer a new therapeutic strategy for the management of septic heart failure, highlighting the cardioprotective effect of LYC as adjunctive therapy for sepsis management.
危险品化学品经营许可证（带存储）